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Influenza A virus (IAV) defective RNAs are generated as byproducts of error-prone viral
RNA replication. They are commonly derived from the larger segments of the viral genome
and harbor deletions of various sizes resulting in the generation of replication incompatible
viral particles. Furthermore, small subgenomic RNAs are known to be strong inducers of
pattern recognition receptor RIG-I-dependent type I interferon (IFN) responses. The present
study identifies a novel IAV-induced defective RNA derived from the PB2 segment of A/
Thailand/1(KAN-1)/2004 (H5N1). It encodes a 10 kDa protein (PB2Δ) sharing the N-terminal
amino acid sequence of the parental PB2 protein followed by frame shift after internal dele-
tion. PB2Δ induces the expression of IFNβ and IFN-stimulated genes by direct interaction
with the cellular adapter protein MAVS, thereby reducing viral replication of IFN-sensitive vi-
ruses such as IAV or vesicular stomatitis virus. This induction of IFN is completely indepen-
dent of the defective RNA itself that usually serves as pathogen-associated pattern and
thus does not require the cytoplasmic sensor RIG-I. These data suggest that not only defec-
tive RNAs, but also some defective RNA-encoded proteins can act immunostimulatory. In
this particular case, the KAN-1-induced defective RNA-encoded protein PB2Δ enhances
the overwhelming immune response characteristic for highly pathogenic H5N1 viruses,
leading to a more severe phenotype in vivo.
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Author Summary
Error-prone polymerase function of RNA viruses can result in expression of defective
RNAs harboring internal deletions of various sizes. Small subgenomic RNAs are strong in-
ducers of the antiviral response by serving as pathogen-associated patterns that are pre-
dominantly detected by cellular sensors. Recently, it has been shown that influenza A virus
defective RNAs are not only generated upon passages in cell culture, but also in infected
humans, indicating that these subgenomic RNAs may also be relevant in infections in
vivo. Here, we characterize a novel defective RNA derived from the PB2 segment of a high-
ly pathogenic H5N1 influenza A virus. This RNA encodes a 10 kDa peptide (PB2Δ) which
activates type I interferon (IFN) responses through direct interaction with the adapter pro-
tein MAVS, a key component of the RIG-I-dependent IFN induction. This is the first time
that such a function was described for a defective RNA-encoded protein, a finding that has
several important implications with regard to deciphering viral protein functions and op-
tions for immunostimulatory approaches. Furthermore, this is an example of how influen-
za viruses may acquire novel polypeptides with altered functions from its limited genome.
Introduction
Influenza A viruses (IAV) belong to the family of Orthomyxoviridae and are characterized by a
segmented single-stranded RNA genome with negative orientation. These eight segments en-
code nine structural and up to seven nonstructural proteins [1–5]. For the production of infec-
tious virus particles at least one copy of each of the segments needs to be packaged into the
progeny particle during the virion assembly step [6].
Non-infectious particles exhibiting an incomplete viral genome e.g. due to a large internal
deletion within at least one segment, are defined as defective interfering particles (DIPs) [7, 8].
These DIPs need the presence of a helper virus for replication of their defective RNA [9]. The
generation of IAV DI RNAs has been linked to the ribonucleoprotein tertiary structure that
leads to jumping of the viral polymerase making transitions between adjacent regions of the
RNA template. Furthermore, there are indications that polymerase skipping is facilitated by
short sequence repeats within viral segments [10]. It has been shown that the competition for
viral RNA polymerases and preferential packaging of over-abundant DI RNA segments inter-
feres with replication and packaging of full-length segments of replication competent helper
virus [7, 8, 11–13].
IAV DI particles have been observed primarily after multiple passages of viruses in cell cul-
ture at high multiplicity of infection or in experimentally infected embryonated chicken eggs
[10, 14, 15] and therefore were considered as experimental artifacts. However, subgenomic
RNAs were isolated recently in vivo from naso-pharyngeal swabs of human patients [16]. The
same study demonstrated that identical in vivo-derived defective RNAs were present in pa-
tients linked by direct contact which might suggest efficient co-transmission between them. It
is thus reasonable to assume that defective RNAs are common byproducts also in natural infec-
tions albeit their function in the biology of influenza viruses and its interactions with the host
remains elusive.
Defective RNAs have been shown to act as efficient pathogen-associated molecular patterns
(PAMPs) recognized more potently by the sensor molecule retinoic acid-inducible gene-I
(RIG-I) than viral genomic segments [17]. This activation of RIG-I leads to the induction of in-
terferon beta (IFNβ) which is one of the key cytokines orchestrating a broadly reactive antiviral
program upon infection [18]. Recently, Tapia and colleagues provided evidence that the
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appearance of defective RNAs coincides with the production of cytokines during IAV infection
[19].
It has been shown previously that some subgenomic RNAs harbor open reading frames that
might be expressed in the presence of a helper virus or could be in vitro translated into poly-
peptides [20, 21]. But, so far, a putative biological function of these proteins has never been an-
alyzed, although they might share sequence similarities with their parental proteins and might
therefore exhibit related or even different functions. In the past years, the discovery of novel
IAV-encoded proteins led to new insights into viral pathogenicity [1–4, 22]. Surprisingly, all
viral nonstructural proteins discovered since 2001 have been shown to be nonessential for viral
replication [1–4] or even possess antiviral activities under certain conditions [23]. However,
several analyses demonstrated that changes in expression levels of these proteins were linked to
virulence in vivo [3, 23, 24]. Therefore, defective RNA-encoded proteins may also contribute to
the course of infections in vivo and could exemplify a mechanism on how influenza viruses ac-
quire novel polypeptides with altered functions from its limited genome.
The present study describes for the very first time a defective RNA-encoded functional poly-
peptide, named PB2Δ. The subgenomic RNA was identified in the H5N1 strain A/Thailand/
KAN-1/2004 (KAN-1). It belongs to the group of defective RNAs derived from the PB2 seg-
ment and potently restricts viral replication by a mechanism independent of DI RNA-mediated
interference. The present study demonstrates that the defective RNA-encoded polypeptide
PB2Δ directly interacts with the mitochondrial antiviral signaling protein (MAVS). In contrast
to the effects of PB2-MAVS interaction, this leads to the induction of IFNβ expression, thereby
diminishing viral replication. Furthermore, the presence of this particular defective RNA-en-
coded protein in KAN-1 infection leads to higher expression levels of antiviral acting genes
also in vivo, resulting in a more severe disease phenotype.
Results
Characterization of PB2Δ defective interfering (DI)-like RNA
In recent years, new influenza encoded non-structural proteins were discovered which could
be either linked to viral polymerase activity [25] or host cell response [3, 22, 26, 27] and are
therefore determinants of viral virulence.
During analysis of a cDNA library generated from total RNAs of A549 cells infected with
different IAV subtypes, cDNAs representing a 618 nt-long RNA were identified in H5N1 strain
A/Thailand/KAN-1/2004-infected cultures. This RNA has sequence identity to the 5’ and 3’ re-
gions of the viral PB2 gene but lacks 1715 nt from the PB2 internal region. Hence, the PB2Δ
RNA retains viral promoter and packaging information required for efficient viral replication
(Fig 1A) and thus possesses a structure that is typical for viral defective interfering RNAs [7].
The internal deletion junction site of the PB2Δ RNA occurs at nucleotide position 240 as ob-
served previously for other defective RNAs with junction sites located around positions 200–
300 in vitro and in vivo [10, 16]. Furthermore, this RNA harbors characteristic defective RNA
sequence motifs as described by Jennings and colleagues (1983) such as the frequent occur-
rence of the sequences 5’..GAA..3’ and 5’..CAA..3’ near the junction site, the number of adeno-
sine residues varying from 2 to 3. In addition, it has been described that identification of the
precise junction is frequently not possible due to local sequence similarities [10]. Here, short re-
peat sequences at the junction site were also observed, although these nucleotides are not delet-
ed but still present at both ends (5’..AGGAAT/AGGAAT..3’) (Fig 1A). Therefore, it can be
concluded that the PB2Δ RNA structurally belongs to the group of viral defective interfering
(DI)-like RNAs.
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Fig 1. Characterization of the H5N1 KAN-1-expressed PB2Δ DI-like RNA. A) Sequence analysis of the PB2Δ DI-like RNA (middle lane) in comparison to
the parental PB2 segment (upper and lower lane). Sequence identity is underlined in PB2 sequences and characteristic DI RNA sequence motives are
displayed in color.B) Northern blot analysis of total RNA isolated from A549 infected with 5 MOI of different H5N1 isolates (KAN-1, Mallard and Vietnam) for
the indicated time points. PB2Δ vRNA and c/mRNA were detected by hybridization probes covering the PB2Δ junction site. Visualization was achieved by
autoradiography. As loading control serves 5S rRNA in ethidiumbromide stained PAA gels.C) A549 cells were infected with 5 MOI of KAN-1 for 8 h,
subsequently viral particles were purified from cell culture supernatants and total RNA was isolated. Total RNA from uninfected or KAN-1-infected A549
served as controls. Detection of PB2Δ RNA and GAPDHmRNAwas performed by qRT PCR and analyzed by agarose gel. B, C)Northern blot and agarose
gel are representative of three independent experiments. D) A549 cells were infected with 0.01 MOI rKAN-1WT or PB2Δ and virus-containing supernatants
were harvested at the time points indicated. Infectivity titers were determined by a standard plaque assay and are depicted as mean (±SD) of one
representative of three independent experiments. ***p0.001; two-way ANOVA, Sidak’s multiple comparisons test. E) Analysis of the relative amount of
viral particles (infectious and noninfectious) in supernatants from (D) by hemagglutination assay. To exclude differences due to different replication abilities of
the two viruses 1x106 infectious particles were used for the assay which is representative for three independent experiments. F) A549 cells were infected with
5 MOI of rKAN-1WT or PB2Δ and 2 h p.i. total RNA was isolated. Expressional changes of PB2Δ RNA were detected by qRT-PCR and are depicted as mean
n-fold (±SD) of one representative out of two independent experiments normalized to rKAN-1 WT. *p0.05; unpaired two-tailed Student’s t-test.G) A549
cells were infected with 1 MOI of rKAN-1WT or PB2Δ and 8 or 24 h p.i. total RNA was isolated. Expressional changes of IFNβmRNA were detected by
qRT-PCR and are depicted as mean n-fold (±SD) of one representative out of two independent experiments normalized to control. *0.05; two-way ANOVA,
Tukey’s multiple comparisons test. Significances between the different time points and to mock infection are not indicated.
doi:10.1371/journal.ppat.1004924.g001
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To test whether PB2Δ RNA was expressed also by closely related H5N1 viruses total RNA
was isolated from A549 cells infected with A/Thailand/1(KAN-1)/2004, A/Vietnam/1203/2004
or A/Mallard/Bavaria/1/2006. A specific Northern blot probe complementary to the junction
site was designed, thus preventing cross-hybridization with the PB2 genomic vRNA under the
hybridization conditions applied. The PB2Δ RNA was detectable only in KAN-1-infected cells
(Fig 1B), although especially the Vietnam strain shows high sequence similarity and sequence
repetition at the junction site within the PB2 gene (S1 Table, NCBI’s Influenza Virus Resource
[28] KAN-1: CY111595.1 and Vietnam: HM006756.1). Interestingly, sequence alignments
showed that this repeat is present in 53% of all known human and 79% of all avian H5N1
strains compared (S1 and S2 Tables), while all other strains show in general only a single nucle-
otide substitution. To exclude that the generation of the PB2Δ RNA was a KAN-1 stock-specific
event, the ability of de novo PB2Δ RNA synthesis was examined for the H5N1 strains KAN-1
and Vietnam. Undiluted passages of plaque-purified clones from PB2Δ-free virus preparations
performed as described by Nayak and colleagues [29] uncovered PB2Δ RNA expression in dif-
ferent passages to various extents for both strains (e.g. KAN-1 clones 8 and 12 as well as Viet-
nam clones 3 and 7; S3 Table). Although PB2Δ RNA expression is a nonessential event and not
specific for KAN-1, this strain seems to exhibit higher PB2Δ expression levels compared to
Vietnam virus.
DI dependent interference is characterized by competition for viral polymerases during rep-
lication of vRNA into cRNA and preferential packaging of over-abundant DI segments [12,
13]. To test whether PB2Δ RNA can be replicated by the viral polymerase complex, Northern
blot hybridization was performed with a specific probe complementary to PB2Δ (+)RNA. As
expected, the presence of PB2Δ (+)RNA upon infection with the KAN-1 isolate was confirmed,
suggesting that the PB2 DI-like RNA is a substrate for the viral polymerase and is amplified
upon viral replication (Fig 1B). This was further verified by strand-specific qRT-PCR, uncover-
ing the existence of all three viral RNA species (S1 Fig).
One further aspect of the interfering activity of defective viral RNAs is the preferential pack-
aging of RNAs which exist at high copy numbers within the cell [12]. The retained 5’ and 3’ re-
gions of the PB2 segment within the PB2Δ RNA suggest that packaging of this smaller RNA
fragment into virions is possible. The presence of PB2Δ vRNA in KAN-1 viral particles was
confirmed by qRT-PCR (Fig 1C). Total RNA from KAN-1- and mock-infected A549 cells
served as controls, showing higher amounts of PB2Δ RNA in infected cells compared to viral
particles which might be due to the detection of PB2Δ RNA in negative and positive orienta-
tion. To exclude contamination of viral RNA with cellular RNA, the presence of GAPDH
mRNA was analyzed, showing no PCR product from total RNA of viral particles (Fig 1C).
Hence, specific expression of PB2ΔDI-like RNA was confirmed and conversion into (+)
RNA was shown, arguing that PB2Δ DI-like RNA serves as a substrate for the viral polymerase.
Furthermore, it is packaged into viral particles and, thus, possesses all crucial features of defec-
tive RNAs owning interfering activity.
To answer the question as to whether the PB2Δ DI-like RNA exhibits interfering activity, a
recombinant KAN-1 virus was produced by reverse genetics [30] harboring PB2ΔDI-like RNA
as additional segment. This method has the advantage that the artificially introduced RNA pre-
dominantly persists over newly originated defective RNAs which are in an inferior position
due to copy numbers [11, 31]. Furthermore, the generation of wild type virus allows the com-
parative analysis with a PB2Δ RNA-free virus.
To investigate whether the PB2ΔDI-like RNA exhibits interfering activity, replication of the
recombinant PB2Δ RNA-expressing KAN-1 (rKAN-1 PB2Δ) and of wild type virus (rKAN-1
WT) were compared (Fig 1D). Although 9 h p.i. there were no differences in viral replication,
infectivity titers were significantly reduced by one log step at all further time points analyzed.
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Furthermore, rKAN-1 PB2Δ indeed induces the production of non-infectious particles as con-
firmed by hemagglutination assay (Fig 1E). This method allows the determination of the rela-
tive amount of particles in a virus suspension with a predefined number of infectious particles
due to the same ability of infectious and non-infectious influenza particles to agglutinate avian
erythrocytes. Here, an increased amount of virus particles was observed at all time points ana-
lyzed which was elevated by a factor of 4 for rKAN-1 PB2Δ infection compared to wild type
virus (Fig 1E). To evaluate whether these differences are due to non-infectious particles in-
duced by the PB2ΔDI-like RNA, whole genomes of both recombinant viruses were sequenced.
This analysis revealed no differences in viral segment sequences neither among each other nor
to the PB2Δ-expressing KAN-1 isolate, whereas a strong expression of PB2Δ m/cRNA for
rKAN-1 PB2Δ was observed (Fig 1F), confirming that the presence of PB2Δ defective RNA in-
deed induces the production of non-infectious particles.
In recent years, increased attention has been paid to defective RNA-induced interferon ex-
pression. The first evidence of an influenza DI RNA inducing IFN expression came from DI
244 which protected wild type mice from lethal infections with heterologous paramyxo- and
influenza B virus, but failed in protection of type I IFN receptor-deficient mice [32, 33]. The
main PAMP that is sensed by different pattern-recognition receptors (PRRs) to induce the
type I IFN response in viral infections is viral RNA. Particularly, detection of the 5’-triphos-
phate (5’-ppp) structure in viral RNAs by the cytoplasmic helicase RIG-I plays an important
role in influenza A virus infection [34]. It has been shown that RIG-I preferentially binds 5’-
ppp-containing small genomic segments and subgenomic RNAs [17]. Moreover, defective
RNA generation coincides with the production of cytokines during IAV infection [19]. In ad-
dition, double-stranded RNAs of more than 30 base pairs in length, often found in snap- or
copyback DI RNAs of Paramyxo- and Rhabdoviridae due to long double-stranded regions,
also can trigger IFN responses [11]. To analyze whether PB2Δ DI-like RNA affects viral repli-
cation via enhancing virus-induced innate immune responses, the expression of IFNβ was de-
termined by qRT-PCR. IFNβ is the most crucial mediator of the innate type I IFN response
upon IAV infection [35]. No differences in IFNβmRNA expression were detectable 8 h p.i.
between the two recombinant viruses (Fig 1G), although PB2Δ RNA was expressed in high
amounts as early as 2 h p.i. (Fig 1F). Interestingly, 24 h p.i. IFNβmRNA levels were signifi-
cantly increased upon infection with rKAN-1 PB2Δ, suggesting that the reduced infectivity ti-
ters may be in part due to the induction of a strong host cell response.
PB2Δ protein impairs viral protein expression without affecting the viral
polymerase complex
Internal deletion of nucleotides within influenza segments during the synthesis of defective
RNAs in general results in truncated RNAs possessing all important sequences for transcrip-
tion and translation. Therefore, the presence of an intact open reading frame (ORF) can result
in the expression of polypeptides from subgenomic RNAs, as previously described [20, 21].
However, so far there are no studies delineating a potential function of these polypeptides in
IAV infection. The PB2Δ RNA comprises the PB2 translational initiation codon followed by a
frameshift downstream of the junction site, leading to early termination after 15 additional
amino acid codons (Fig 2A). To test whether this potential ORF leads to the generation of a
polypeptide from the PB2ΔmRNA, viral protein expression was analyzed. Antibodies directed
against the PB2 N-terminus were used, a region that would be identical in both proteins. A dis-
tinct protein band around 10 kDa emerged 5 h p.i. that was not observed upon infection with
other IAV isolates of various subtypes (Fig 2B). Furthermore, the existence of this protein in
KAN-1-infected cells was confirmed by mass spectrometry (S2 Fig). To verify that it is encoded
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by PB2ΔmRNA, a specific siRNA was designed covering the conserved regions flanking the
junction site (Fig 1A) thus limiting interference with viral PB2 RNA. Viral protein expression
was analyzed in the presence or absence of PB2Δ-specific siRNA (Fig 2C). As expected, the
small PB2-like protein encoded by the PB2Δ RNA was down-regulated, whereas the expression
of PB2 was not reduced. Interestingly, especially 5 h p.i. there was a slight increase in viral pro-
tein expression observable when PB2Δ was knocked down which might suggest a function of
the small protein in viral protein expression. Another explanation would be a simultaneous
knockdown of PB2Δ v/cRNA leading to a more efficient replication of KAN-1 due to the pre-
vention of non-infectious particles. To analyze whether viral replication is affected by siRNA-
mediated knockdown of PB2Δ RNA species, A549 cells were infected with KAN-1 for 8 h (Fig
2D, above). Although the KAN-1 isolate is well adapted to cell culture and replicates efficiently
in A549 to high viral titers, there was a slight increase in viral replication observable when
PB2Δ was knocked down (Fig 2D, below). Furthermore, expression of PB2Δ protein was com-
pared in rKAN-1 WT and rKAN-1 PB2Δ infection. As expected, the PB2Δ protein was only de-
tectable in rKAN-1 PB2Δ-infected cells concomitant with decreased expression levels of other
viral proteins (S3 Fig).
Thus, the viral PB2Δ defective RNA is efficiently transcribed into mRNA that is translated
to a truncated 10 kDa protein. The data further suggest that this polypeptide might fulfill an
antiviral function in influenza virus replication.
In order to analyze a potential function of the PB2Δ protein, an expression vector containing
the PB2Δ ORF was generated. Initially, viral protein expression was analyzed in the presence or
absence of PB2Δ in A549 cells infected with KAN-1. Interestingly, overexpression of PB2Δ led
to a significant reduction in viral protein expression (Fig 2E). This could be attributed at least
in part to the fact that the expression of viral mRNAs such as PB2 and M1 was reduced in the
presence of PB2Δ (Fig 2F), although not significant for PB2 and effects on protein levels were
more pronounced (Fig 2E).
Due to its function as part of the viral polymerase complex, the IAV protein PB2 has been
linked to viral pathogenicity and host adaptation [36, 37]. There are several mutations known
that verifiably affect viral polymerase activity and thus have an impact on viral replication [38,
39]. Comparative analysis of the viral proteins PB2 and PB2Δ showed sequence identity within
the N-termini (Fig 2A), comprising the binding sites for the viral PB1 protein. Nuclear interac-
tion with PB1 is essential for the generation of an active viral polymerase complex. Therefore,
the decreased expression of viral mRNAs might be due to a reduced viral polymerase activity
caused by direct interaction of PB2Δ with the polymerase complex. To test this hypothesis, co-
immunoprecipitation of the viral polymerase complex was performed by using antibodies spe-
cific for the viral nucleoprotein (NP). The polymerase subunits PB1 and PB2 were efficiently
Fig 2. The PB2Δ mRNA encodes a 10 kDa protein that impairs viral gene expression. A) Sequence alignment of the PB2Δ protein in comparison to PB2.
B)Western blot analysis of total lysates of A549 infected with 5 MOI of different influenza viruses of the subtypes H5N1 (KAN-1, Mallard, Vietnam; right),
H7N7 (FPV) and H1N1 (PR8) (left). PB2Δ and PB2 were detected 3, 5, 8 and 12 h p.i.. Equal loading was verified by the detection of total ERK2. C, D) A549
cells were transfected with PB2Δ-specific or scrambled siRNA and subsequently infected with KAN-1 (C: MOI 5, D: MOI 2) for the indicated time points.C)
Expression of viral proteins PB1, PB2, NP, M1 and NS1 upon PB2Δ knockdown was analyzed byWestern blot. Knockdown efficiency was verified by using
PB2-specific antibodies. ERK2 expression served as loading control. D) Changes in infectivity titers upon PB2Δ knockdown were determined by standard
plaque assay and are depicted as mean (±SD) of six independent experiments (above). **p0.01, unpaired two-tailed Student’s t-test. Efficient knockdown
of PB2Δ was verified byWestern blot analysis (below). Efficient infection was confirmed by immunodetection of viral PB2 and equal loading was verified by
analysis of total ERK2 expression. E, F) A549 cells were transfected with PB2Δ or empty vector and subsequently infected with 5 MOI KAN-1 for the
indicated time points. E) Expression of viral proteins PB1, PB2, NP, M1 and NS1 was analyzed byWestern blot. Overexpression of PB2Δ was confirmed by
using Myc-specific antibodies. Equal loading was verified by detection of total ERK2. F) Expression levels of viral m/cRNAs were detected by qRT-PCR and
are depicted as mean n-fold (±SD) of one representative out of two independent experiments normalized to 15 min infection of empty vector-transfected cells.
*p0.05, two-way ANOVA, Sidak’s multiple comparisons test.G) A549 cells were infected with 5 MOI KAN-1 for 8 h. Subsequently, co-immunoprecipitation
of the viral polymerase complex was performed by using NP-specific antibodies. Efficient immunoprecipitation was confirmed by detection of viral proteins
NP, PB1 and PB2. Presence of PB2Δ was analyzed by PB2-specific antibodies. B, C, E, G) Blots are representative of three independent experiments.
doi:10.1371/journal.ppat.1004924.g002
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co-immunoprecipitated, whereas PB2Δ was only detectable in the input control (Fig 2G).
Therefore, reduced levels of viral mRNA expression in the presence of PB2Δ are unlikely to be
caused by a modulation of viral polymerase activity induced by direct interaction of PB2Δ with
the polymerase complex.
PB2Δ interacts with the adapter protein MAVS
Another more indirect mode of interference with viral protein expression would be the en-
hancement of the IAV-induced antiviral host cell response. One of the most potent mediators
of this response is IFNβ. Beside its role in viral replication, PB2 also participates in the evasion
of the antiviral immune response mediated by direct interaction with the mitochondrial antivi-
ral signaling protein (MAVS) [40]. The latter is of particular importance in the RIG-I-mediated
signal transduction upon detection of viral RNA which results in the expression of type I IFNs
[41–43]. It has been shown that the protein-protein interaction of MAVS and PB2 is mediated
by N-terminal amino acids 1–37 of the viral PB2 protein [44] which are present in PB2Δ (Fig
2A). Therefore, an interaction with the cellular MAVS protein affecting IAV-induced IFNβ ex-
pression is likely to occur.
To test this hypothesis, HEK293 cells were transfected with plasmids expressing HA-tagged
MAVS in combination with expression plasmids for Myc-tagged PB2Δ or Myc-tagged PB2, re-
spectively. 24 h p.t. HA-tagged MAVS was precipitated with HA-specific antibodies and the
presence of co-precipitating proteins was analyzed. As expected, co-precipitation with cellular
MAVS was confirmed not only for viral PB2 but also for the PB2Δ protein (Fig 3A).
It has been shown that the IAV PB2 protein exhibits an N-terminal mitochondrial-targeting
signal, leading to the association of PB2 with mitochondria where it can interact with MAVS
which needs mitochondrial localization to fulfill its signaling functions [40, 42, 45]. To analyze
whether PB2Δ is also associated with mitochondria and whether this localization is dependent
on the presence of MAVS, mitochondria were isolated from MAVS siRNA-transfected A549
cells that were subsequently infected with KAN-1. As expected, knockdown of MAVS led to a
reduced mitochondrial localization of PB2Δ that was even more pronounced compared to that
of viral PB2 protein (Fig 3B).
To analyze whether this interaction might affect MAVS-induced IFNβ expression, reporter
gene assays were performed. A construct containing the luciferase gene under control of the
entire IFNβ promoter harboring all transcription factor binding sites responsible for the forma-
tion of the IFNβ enhanceosome was used. As expected, empty vector-transfected cells exhibited
no luciferase activity when viral proteins were co-expressed (Fig 3C). The presence of the
MAVS protein led to a strong induction of the IFNβ promoter activity that was even increased
when PB2Δ was co-expressed. In clear contrast, the full-length PB2 protein resulted in a de-
creased promoter activity, confirming earlier findings [40]. Interestingly, the presence of PB2Δ
in PB2/MAVS-expressing cells compensated for the PB2-mediated decrease in IFNβ promoter
activity, resulting in the same level of luciferase expression as observed for MAVS/PB2Δ-ex-
pressing cells. This MAVS-mediated mechanism of antiviral gene expression induced by PB2Δ
was confirmed on endogenous levels by siRNA-mediated knockdown of MAVS. In this MAVS
deficient situation, infection with a PB2Δ-positive virus led to the same levels of IFNβ and ISG
mRNAs as observed in WT virus infection (Fig 3D). Since MAVS does not only participate in
IFN induction but leads to the activation of different transcription factors inducing the expres-
sion of pro- and anti-inflammatory cytokines [41–43, 46], the expression of IL-6, a primarily
NFκB-dependent cytokine, was analyzed in the presence of PB2Δ. As expected, IL-6 mRNA ex-
pression was also increased in presence of PB2Δ showing the same dependency on MAVS
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Fig 3. PB2Δ interacts with MAVS at mitochondria thereby inducing IFNβ expression. A)Hek293 cells were transfected with HA-MAVS or empty vector
in combination with Myc-PB2Δ, Myc-PB2 or empty vector. 24 h p.t. co-immunoprecipitation was performed by using HA-specific antibodies. Analysis of the
co-immunoprecipitation of PB2 and PB2Δ was performed by detection of the Myc-tag. Blots are representative of three independent experiments. B) A549
cells were transfected with MAVS-specific or scrambled siRNA and subsequently infected with 5 MOI KAN-1. At the indicated time points, mitochondria were
isolated and the presence of viral proteins PB2Δ and PB2 was analyzed byWestern blot. Knockdown efficiency was verified by using MAVS-specific
antibodies. Tubulin expression served as loading control.C)Hek293 cells were transfected with the IFNβ promoter in combination with HA-MAVS or empty
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signaling as observed for IFN and ISGs, suggesting that PB2Δ leads to the activation of the full
set of MAVS effector functions.
The results collectively demonstrate that PB2Δ can interact with MAVS, forming a function-
al complex that induces the expression of IFNβ, ISGs and other cytokines.
PB2Δ induces the expression of IFNβ, thereby restricting viral replication
It is well known that influenza virus proteins such as the nonstructural proteins NS1 and
PB1-F2 or the components of the heterotrimeric polymerase complex modulate IFNβ induc-
tion [26, 27, 47, 48], although in an inhibitory manner.
To analyze whether overexpression of PB2Δ protein would interfere with IAV-mediated
expression of IFNβ and alter the induction of interferon-stimulated genes (ISGs), KAN-1-in-
duced mRNA levels of different antiviral acting genes were analyzed (Fig 4A). Indeed, overex-
pression of PB2Δ led to a strong interference with IFNβmRNA induction that was detectable
even in mock-infected cells, however, expression of the cytokine was strongly increased rather
than inhibited. According to this, the expression of ISGs such as IP10 was also enhanced.
To gain insight into the role of PB2Δ-induced stimulation of the innate immune response in
viral replication, infectivity titers were determined in the presence or absence of PB2Δ. KAN-1
replication was significantly reduced by more than 10-fold when PB2Δ was overexpressed (Fig
4B). Furthermore, this impaired viral propagation was most likely a consequence of the induc-
tion of type I IFN as demonstrated by infection of type I IFN-deficient Vero cells, where PB2Δ
expression did not decrease infectivity titers (Fig 4C). This was confirmed by pretreatment of
A549 cells with conditioned media of PB2Δ-transfected cells leading to a significant decrease in
infectivity titers around 100-fold (Fig 4D). This suppression was recovered by specific knock-
down of IFNα/β receptor chain 2 (IFNAR2) in the acceptor cells or enrichment of conditioned
media with neutralizing IFNβ antibodies. Efficient interference with PB2Δ-induced type I IFN
is demonstrated by reduced STAT1 Tyr701 phosphorylation which led to recovery of viral pro-
tein expression (Fig 4E). To analyze whether this PB2Δ-dependent IFN induction is sufficient
to inhibit replication of other IFN-sensitive viruses as well, A549 cells were infected with vesic-
ular stomatitis virus (VSV), showing significantly reduced replication in the presence of PB2Δ
(Fig 4F).
In summary, the defective RNA-encoded protein PB2Δ acts antiviral by the induction of
type I IFN and ISGs, thereby inhibiting viral propagation of IFN-sensitive viruses.
Presence of PB2Δ leads to a more severe in vivo phenotype by
enhancing early innate immune responses
The induced cytokine storm during severe influenza infections leads to major morbidity and
mortality. A significant association between excessive early cytokine response, immune cell re-
cruitment and poor outcome has been documented for highly pathogenic avian H5N1 virus in-
fections [49]. To investigate the role of PB2Δ in the induction of the innate immune response
in vivo, BALB/c mice were infected with 50 pfu rKAN-1 WT in comparison to a PB2Δ-positive
vector as well as with PB2Δ, PB2, PB2Δ/PB2 or empty vector. 24 h p.t. promoter activity was measured by luciferase assay. Depicted are mean percentages
(±SD) of four independent experiments. *p0.05, **p0.01; two-way ANOVA, Tukey’s multiple comparisons test. D) A549 cells were transfected with
MAVS-specific or scrambled siRNA and subsequently infected with 0.5 MOI rKAN-1WT or PB2Δ for 24 h. Expression levels of cytokines and ISGs were
detected by qRT-PCR and are depicted as mean n-fold (±SD) of one representative out of three independent experiments normalized to non-infected control
cells. *p0.05, two-way ANOVA, Sidak’s multiple comparisons test. Knockdown efficiency was verified byWestern blot analysis using MAVS-specific
antibodies. Presence of PB2Δ was analyzed by PB2-specific antibodies and Tubulin expression served as loading control. Blots are representative of two
independent experiments.
doi:10.1371/journal.ppat.1004924.g003
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virus. Two days post infection, mouse lungs were extracted and total RNA was isolated for
qRT-PCR. Fig 5A shows lung ISG mRNA levels normalized to PBS-treated control mice. Al-
though differences in IFNβmRNA levels between PB2Δ-negative and—positive KAN-1 viruses
were not significant at the time point analyzed (S4A Fig), different ISGs such as OAS-1 and
IRF7 showed considerably increased expression levels in presence of PB2Δ, while virus replica-
tion was not significantly altered at that time (S4B Fig).
Dysregulation of the innate cytokine response indicates disease severity and death during
HPAIV infection [49, 50]. To analyze whether PB2Δ-induced ISG expression has an impact on
disease severity of KAN-1 infection, BALB/c mice were infected with 50 pfu of wild type or
PB2Δ-expressing virus. While in presence of PB2Δmice lost body weight as early as 4 days post
infection, weight loss in WT-infected mice was delayed and was not detectable until day 6 p.i.
(Fig 5B, left). This is supported by the survival curves which show the tendency to earlier death
of PB2Δ-infected mice, although this result is not significant.
These findings demonstrate that defective RNA-encoded PB2Δ protein-induced amplifica-
tion of early innate immune responses leads to enhanced disease severity in KAN-1 infection
and impressively emphasizes the role defective RNA-encoded proteins could play in viral path-
ogenicity of IAV.
Discussion
The generation of IAV defective interfering particles upon serial passages at high multiplicity
of infection in vitro has been well described and in recent years there is increasing evidence
that influenza defective RNAs are naturally occurring also in vivo [16]. It is still discussed why
non-infectious particles are produced upon infection in many or possibly all animal virus sys-
tems and defective viruses have been ignored as possible important determinants in the out-
come of natural virus infections for years [9]. Generation of non-infectious particles might be
induced by the host, thereby restricting viral replication and boosting innate immune re-
sponses. One further possibility is that DI particles have evolved as an adaptive measure of the
virus, thereby enabling persistent infections to allow further spread in a population, especially
in the case of highly pathogenic viruses whose infections are associated with high mortality
rates. Furthermore, the non-infectious particle population contains transcriptionally compe-
tent gene segments that can be complemented through coinfection [51]. Natural infection of
an animal host involves interplay between physically and genetically heterogeneous virions and
a mixed collection of wildly different cell types of varying susceptibility in combination with a
dynamic and complex immune response. Therefore, genetic variability induced by error-prone
polymerases is an evolutionary advantage that is strongly promoted by non-infectious particles
[52]. Recently, Saira and colleagues showed that in vivo-derived DI-like RNAs were similar to
Fig 4. PB2Δ increases virus-induced expression of IFNβ, thereby restricting viral replication of IFN-sensitive viruses. A) A549 cells were transfected
with PB2Δ or empty vector and subsequently infected with 5 MOI KAN-1. At the time points indicated total RNA was isolated and expressional changes of
IFNβ or IP10 mRNAs were analyzed by qRT-PCR and are depicted as mean n-fold (±SD) of one representative out of two independent experiments
normalized to empty vector-transfected control. Efficient transfection was confirmed by detection of PB2Δ mRNA. *p0.05; ***p0.001; two-way ANOVA,
Sidak’s multiple comparisons test.B, F) A549 or C) Vero cells were transfected with PB2Δ or empty vector and subsequently infected with B) 0.01 MOI KAN-
1, C) 0.001 MOI KAN-1 or F) 0.01 MOI VSV. At the time points indicated virus-containing supernatants were harvested and infectivity titers were determined
by a standard plaque assay and are depicted as mean (±SD) of three independent experiments. **p0.01, ***p0.001; two-way ANOVA, Sidak’s multiple
comparisons test. D, E) A549 cells were transfected with PB2Δ or empty vector and 32 h p.t. conditioned media were transferred to IFNAR2 siRNA-
transfected A549 cells or were enriched with neutralizing IFNβ antibody and transferred to untreated A549 cells. 16 h p.s. acceptor cells were infected with
0.1 MOI rKAN-1WT for 24 h. D) Infectivity titers were determined by standard plaque assay and are depicted as mean (±SD) of one representative out of
three independent experiments. *p0.05; **p0.01; ***p0.001; two-way ANOVA, Dunnett’s multiple comparisons test relating to empty vector-
conditioned media-treated control cells, respectively. E) Expression of viral proteins PB2, NP, M1 and NS1 in conditioned medium-treated acceptor cells
upon IFNAR2 knockdown or IFNβ neutralization was analyzed byWestern blot. Knockdown and neutralization efficiencies were verified by using phosphor-
STAT1 Tyr701 antibodies. Tubulin expression served as loading control. Blots are representative of three independent experiments.
doi:10.1371/journal.ppat.1004924.g004
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those generated in vitro and that the presence of identical DI-like RNAs in patients linked by
direct contact is compatible with transmission between them [16]. Therefore, a functional role
of DI-like RNAs in natural infections seems not unlikely. Here, we investigated the molecular
mechanisms by which defective particles, harboring a specific PB2-derived subgenomic RNA
that encodes a 10kDa protein, inhibit H5N1 KAN-1 viral replication.
Fig 5. Effects of PB2Δ on viral pathogenesis in vivo. BALB/c mice were infected with 50 pfu rKAN-1 wild type or PB2Δ-expressing virus. A) Expression
changes of ISGmRNAs in lungs were analyzed two days p.i. by qRT-PCR. N-fold expression in individual animals normalized to uninfected PBS control mice
is depicted. *p0.05, **p0.01: Mann-Whitney test.B) Body weight curves; mean% body weight of 1–9 (initial group size) animals normalized to initial
weight +/-SEM is depicted. *p-values range between 0.014 and 0.049, Mann-Whitney test. Animals were excluded from the analysis when reaching less
than 80% of the initial body weight. Survival curves; %-survival of 1–9 (initial group size) animals is depicted. Statistical significance was analyzed by Gehan-
Breslow-Wilcoxon test.
doi:10.1371/journal.ppat.1004924.g005
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Beside DIP-induced interference mediated by competition for viral polymerases and prefer-
ential packaging of over-abundant DI segments [12, 13], recent reports show that subgenomic
RNAs can act as potent immune stimulators [17, 19, 32, 33]. It has been observed that the cyto-
plasmic PRR RIG-I preferentially binds small genomic and subgenomic RNAs [17] and there is
evidence that the appearance of defective RNAs coincides with the production of cytokines
during IAV infection [19]. Here, overexpression of the defective RNA-encoded protein PB2Δ
per se was sufficient to induce transcription of IFNβmRNA, whereupon subsequent infection
led to a further increase in IFNβ expression. In addition, KAN-1-induced expression of IFNβ
and subsequently that of ISGs seems to be primarily induced by the PB2Δ protein and not by
the detection of the defective RNA itself. This was shown by the recombinant PB2Δ-expressing
virus which induced increased IFNβ levels only late upon infection although considerable ex-
pression of PB2Δ RNA was detectable already 2 h p.i.. These data suggest that not only defective
RNA but also some defective RNA-encoded proteins can act immunostimulatory. Further-
more, the PB2Δ protein-mediated IFN induction is completely independent of the detection of
subgenomic RNA by the cellular sensor RIG-I but comprises complex formation with the
adapter protein MAVS.
MAVS is of primary importance for RIG-I-mediated signal transduction upon sensing of
viral PAMPs resulting in the expression of type I IFNs [41–43]. It has been shown that the PB2
protein interferes with IFNβ expression by direct interaction with MAVS via its binding site lo-
cated within aa 1–37 [44]. It was hypothesized that PB2 binding leads to the inactivation of the
MAVS complex by inhibition of intermolecular conformational changes needed for oligomeri-
sation [44]. Here, PB2Δ binding of MAVS per se activates MAVS-mediated IFN induction.
This suggests that not the binding of PB2 itself inhibits MAVS signaling but rather leads to a
transition of the cellular protein into the active form, whereas the C terminal part of the viral
protein interferes with induction of signal transduction. Thus, it is very likely that the C-termi-
nus of PB2 inhibits MAVS oligomerisation or the interaction with downstream acting kinases
such as TBK-1, TAK-1 or IKK or different transcription factors like IRF3 or IRF7 which are
normally recruited by the adapter protein [41, 43, 46].
Interestingly, there was no interaction of PB2Δ with the viral polymerase complex observ-
able although the binding site within PB2 mediating the interaction with MAVS is also in-
volved in PB1 binding [44, 53]. This might be attributed to the tertiary structure of PB2Δ. The
binding site for MAVS and PB1 consists of 3 α-helices, of which the first establishes the inter-
action between PB1 and PB2 [53], whereas in the case of MAVS, helix 3 carries this function
[44]. Therefore, specific folding of PB2Δ or steric inhibition by its C-terminus might lead to
masking of helix 1, thereby inducing preferential binding of MAVS or even disabling PB1 bind-
ing. One further possibility would be the primary mediation of the PB1-PB2 interaction by an
alternative PB1 binding site identified within the C-terminus of the PB2 protein [54]. There-
fore, the present study reveals that functional analysis of defective RNA-encoded proteins can
help to understand the biological characteristics of the parental viral protein and its interac-
tions with viral and/or host factors.
The interaction of MAVS and PB2Δ at mitochondria increases IAV-induced type I IFN ex-
pression leading to reduced infectivity titers in the presence of PB2Δ. Therefore, the present
study links for the first time a biological function to an IAV defective RNA-encoded protein. In
addition, PB2Δ is an antiviral acting protein whose action is not restricted to influenza A virus
infection, but also limits the replication of other IFN-sensitive viruses as shown by VSV infec-
tion. Therefore, this peptide or a low-molecular peptidomimetic thereof might be useful as an-
tiviral agent for IFN-sensitive viruses.
Interestingly, sequence alignments of human and avian H5N1 isolates showed that 53% or
79%, respectively, harbor the short sequence repeat at the junction site as observed for PB2Δ
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RNA which could be responsible for polymerase skipping, suggesting that these IAV isolates
might also evolve a defective RNA similar to KAN-I PB2Δ upon passaging and/or transmission
in vivo. This was supported by the finding that serial undiluted passaging of PB2Δ-free propa-
gations of H5N1 strains KAN-1 and Vietnam led to the de novo generation of PB2Δ RNA to
various extents. These data highlight different expression patterns of the same RNA within dif-
ferent preparations of the same virus strain and possibly explains different phenotypes of the
same virus strain propagated in different laboratories.
Whether there are additional cis- or trans-mutations needed to facilitate generation of these
defective RNAs has to be further studied. The apparent late expression of the PB2Δ protein
compared to its RNA might suggest that there are other sequences or structures needed that
support the translation of PB2Δ.
In summary, PB2Δ is a virulence factor in H5N1 KAN-1 infections that restricts viral repli-
cation by modulation of the antiviral host gene response. Infections with highly pathogenic
avian influenza viruses are characterized by a hyperactivation of the host immune response
leading to an excessive expression of proinflammatory cytokines. This so called ‘cytokine burst’
has been discussed to be decisive for disease outcome [49, 50, 55]. Therefore, although PB2Δ is
an antiviral acting protein in cell culture, its presence in KAN-1 infections in vivo enhances the
induction of innate immune responses and thereby is involved in increased pathogenicity.
Graef and colleagues hypothesized that the reduced PB2-induced suppression of MAVS-medi-
ated signal transduction upon infection with avian influenza viruses in comparison to human
subtypes might play a role in HPAIV-induced dysregulation of cytokine expression [40]. The
adapter protein MAVS is not only essential for the induction of IFNβ but plays a role directly
and indirectly in the induction of interferon-stimulated response element (ISRE)-regulated
and proinflammatory genes by activation of transcription factors IRF3 (interferon regulatory
factor 3) and NF-κB (nuclear factor kappa-light-chain-enhancer of activated B-cells) [41–43,
46]. In this context, it has already been shown that the early suppression of cytokine amplifica-
tion significantly leads to the protection of mice from lethal IAV infection [56, 57]. Therefore,
in context of KAN-1 infection, targeting PB2Δmight be a promising approach to reduce disease
manifestation by the suppression of immunopathology.
Overall, the present study provides evidence for the very first time that polypeptides en-
coded by influenza virus defective RNAs can fulfill biological functions that are associated but
must not coincide with the activities of the parental full-length protein. Furthermore, subge-
nomic RNA-encoded polypeptides seem to play a prominent role in influenza virus pathoge-
nicity, therefore the analysis of their functions leads to deeper understanding of the biology of
influenza virus infections and its interactions with the host.
Materials and Methods
Ethics statement
All animal studies were performed in compliance with animal welfare regulations of the Ger-
man Society for Laboratory Animal Science (GV-SOLAS) and the European Health Law of the
Federation of Laboratory Animal Science Associations (FELASA). The protocol was approved
by the relevant authorities in Hamburg (Behörde für Gesundheit und Verbraucherschutz)
under the license number Az 42/13.
Viruses and cells
A/Thailand/KAN-1/2004 (H5N1; KAN-1) was used with kind permission from P. Putha-
vathana (Bangkok, Thailand). Recombinant A/Vietnam/1203/2004 (H5N1; Vietnam) and A/
Puerto-Rico/8/34 (H1N1; PR8) were described before [58, 59]. A/FPV/Bratislava/79 (H7N7;
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fowl plaque virus, FPV) was a kind gift from S. Pleschka (Institute of Virology, Giessen, Ger-
many) and A/Mallard/Bavaria/1/2006 (H5N1, Mallard) was obtained from O. Planz (Interfac-
ulty Institute for Cell Biology, Tübingen, Germany). All experiments and handling of samples
containing H5N1 or H7N7 infectious particles were performed in a biological safety level 3
containment. Influenza viruses as well as vesicular stomatitis virus strain Indiana (VSV) were
propagated on Madin-Darby canine kidney (MDCKII) cells cultured in minimal essential me-
dium (MEM, PAA Laboratories) containing 10% v/v FCS (Invitrogen) as described elsewhere
[25]. Human alveolar epithelial cells (A549), green monkey epithelial cells (Vero) and human
embryonic kidney 293 cells (HEK293) were cultured in Dulbecco’s modified eagle medium
(DMEM, PAA Laboratories) containing 10% v/v FCS. All cell lines were originally purchased
from ATCC and have been passaged in the laboratory. At regular intervals cells are checked for
their identity by SNP-profiling (Multiplexion).
Plasmids
The luciferase reporter construct pTATA-IFNβ-luc containing the whole IFNβ enhanceosome
upstream of a luciferase gene was a kind gift from J. Hiscott (Vaccine & Gene Therapy Institute
of Florida, Port Saint Lucie, Florida, USA). pHW2000-PB2Δ was obtained by reverse transcrip-
tion of the A/Thailand/KAN-1/2004 PB2ΔDI RNA by using influenza A segment one specific
universal 12 primers [60] and subsequent PCR amplification. PB2ΔDI DNA was then cloned
into the bidirectional pHW2000 plasmid [30] by using Eco31I restriction enzyme. pcDNA3-
6xMyc-PB2Δ was obtained by PCR amplification of the open reading frame of PB2Δ that was
subsequently cloned into pcDNA3-6xMyc by using EcoRV and XhoI restriction enzymes.
Cloning of the PB2 gene into pcDNA3-6xMyc was performed the same way by Ludmilla Wix-
ler (Institute of Molecular Virology, Muenster, Germany). Primer sequences are included in S4
Table. pCAGGS-HA-MAVS was a kind gift from B. Dauber (Robert Koch Institute, Berlin,
Germany).
Generation of recombinant viruses
A set of eight plasmids based on the bidirectional pHW2000 plasmid allowing the rescue of the
recombinant wild-type (WT) of influenza A/Thailand/KAN-1/2004 was used with kind per-
mission from J. Stech (Friedrich-Loeffler-Institute, Riems, Germany). The generation of the re-
combinant viruses was carried out as described elsewhere [25, 30].
Plaque titration
Plaque forming units of a given virus suspension were determined by a standard plaque assay
as described earlier [61].
Hemagglutination assay
Serial 2-fold dilutions of virus supernatants (1x106 infectious particles, according to 1 HA unit
of rKAN-1 WT stock) were prepared in V-bottomed microtiter plates in a total volume of 50 μl
PBS, the latter also serving as negative control. 50 μl of solution of 1% chicken erythrocytes
(Rockland Immunochemicals, Inc) in PBS were added to the wells and microtiter plates were
incubated for 30 min at 4°C. Hemagglutination was monitored by photography.
Transfection of siRNA and plasmid DNA
PB2Δ siRNA (5’-AGGAAUAGGAAUGAGAAUA-3’), MAVS siRNA (5’-GCUGAAGACAA
GACCUAUA-3’), IFNAR2 siRNA (5’-GAAGCAUAAACCCGAAAUA-3’) and control siRNA
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(5’-UUCUCCGAACGUGUCACGU-3’) were synthesized by MWG-Biotech AG. Transfection
with PB2Δ siRNA was performed with HiPerFect (Qiagen), MAVS and IFNAR2 siRNAs were
transfected by the use of Lipofectamine 2000 (Invitrogen) according to the manufacturer’s pro-
tocols. Infections were carried out 16–48 h p.t. and conditioned medium experiments 36 h p.t..
Plasmid DNA was transfected using Lipofectamine 2000 (Invitrogen) consistent with manufac-
turer’s instructions and infections were carried out 24 h p.t..
Western blot analysis and antibodies
Cells were lysed in radioimmunoprecipitation assay (RIPA) buffer containing protease and
phosphatase inhibitors [61]. Mitochondria were isolated by using the Mitochondria Fraction-
ation Kit from BioVision according to the manufacturer’s protocol. RIPA protein lysates were
cleared by centrifugation, lysates were separated by SDS-PAGE and blotted onto nitrocellulose
membranes. Antisera directed against ERK2 (C-14) and influenza A PB1 (vK-20) were pur-
chased from Santa Cruz Biotechnology and anti-α-Tubulin from Sigma-Aldrich. Antibody
against influenza A PB2 protein was a kind gift of E. Fodor (Sir William Dunn School of Pa-
thology, Oxford, UK [45]. Influenza A M1 and NP antibodies were obtained from AbD Serotec
and mouse monoclonal antibody against influenza A NS1 (23–1) was developed at the Institute
of Molecular Virology (Muenster, Germany) and can be purchased from Santa Cruz Biotech-
nology. MAVS (AT107) antibody was obtained from Alexis Biochemicals and anti-Myc (9E10)
from ATCC. Antibody against phosphor-STAT1 Tyr701 (clone 14) was purchased from BD
Transduction Laboratories. Neutralizing IFNβ antibody was obtained from Abcam and used in
a concentration of 4 μg/ml conditioned medium.
Mass spectrometry
For proteome analyses 100 μg of protein mixtures from KAN-1-infected A549 cells were sepa-
rated on a one-dimensional gel, the lanes were cut into twelve slices each and in-gel digested by
trypsin as described previously [62]. Peptide fractions were collected and desalted separately
using C18 StageTips [63]. LC-MS/MS analyses were performed on an EasyLC nano-HPLC
(Proxeon Biosystems) coupled to an LTQ Orbitrap Elite mass spectrometer (Thermo Scientif-
ic) as described previously [64]. Briefly, the peptide mixtures were injected onto the column in
HPLC solvent A (0.5% acetic acid) at a flow rate of 500 nl/min and subsequently eluted with an
87-min segmented gradient of 5–90% HPLC solvent B (80% ACN in 0.5% acetic acid). During
peptide elution the flow rate was kept constant at 200 nl/min. For proteome analysis the 20
most intense precursor ions were sequentially fragmented by CID in each scan cycle. Se-
quenced precursor masses were excluded from further selection for 90 s. The target values for
the LTQ were 5000 charges (MS/MS) and 106 charges (MS).
The MS data were processed using default parameters of the MaxQuant software (v1.2.2.9)
[65]. Extracted peak lists were submitted to database search using the Andromeda search en-
gine [66] to query a target-decoy databases [67] consisting of the uniprot human proteome da-
tabase (88,692 protein entries, downloaded on the 25th of February 2014), of H5N1 virus
database (13 entries, including the sequence of PB2Δ) and 248 commonly observed contami-
nants. In database search, full tryptic specificity was required and up to two missed cleavages
were allowed. Carbamidomethylation of cysteine was set as fixed modification; protein N-ter-
minal acetylation, and oxidation of methionine were set as variable modifications. Mass toler-
ances were set to 6 ppm at the precursor and 0.5 Da at the fragment ion level, respectively.
False discovery rates were set to 5% at peptide, and protein group level and the minimum pep-
tide length was set to five amino acids.
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Co-immunoprecipitation
Cells were lysed with RIPA or Triton lysis (TLB) buffer [68] containing protease and phospha-
tase inhibitors. Lysates were cleared by centrifugation and supernatants were incubated o/n at
4°C with the antibodies indicated coupled to protein A/G-conjugated agarose (Roche). Com-
plexes were washed three times with lysis buffer (5 min overhead shaking, 4°C) and resolved by
SDS-PAGE with subsequent electrotransfer onto nitrocellulose membranes.
Luciferase reporter gene assays
Transfection of HEK293 with the IFNβ luciferase reporter plasmid (0.25 μg) in combination
with the different expression plasmids (1 μg in total) was performed with polyethylenimine
(PEI) as described elsewhere [69]. Luciferase assays were carried out 24 h p.t. as previously de-
scribed [70]. Relative light units were normalized to protein concentrations determined with a
standard Bradford assay.
RNA isolation, cDNA synthesis and qRT-PCR
Total RNA from cells was isolated using the RNeasy Kit (Qiagen) according to the manufactur-
er’s instructions. Lungs from mice were collected at the time points indicated and total RNA
was isolated using TRIzol reagent (Invitrogen). TRIzol lysis was performed according to the
manufacturer's protocol, introducing a secondary phase separation step as described previously
[57].
Three micrograms of total RNA were reverse transcribed with RevertAid HMinus Reverse
Transcriptase (MBI Fermentas) and oligo(dT) (MWG-Biotech AG) or random hexamer (Fer-
mentas) primers according to the manufacturer’s protocol.
Strand-specific qRT PCR for distinguishing influenza v/c/mRNAs was performed as de-
scribed previously [71]. Briefly, 200 ng of total RNA were reverse transcribed with RevertAid
Premium Reverse Transcriptase (MBI Fermentas) and 10 pmol of each primer (specific for v/
c/mRNAs and Oligo(dT)) according to the manufacturer’s instructions.
The cDNA was used for qRT-PCR, which was performed using a Roche LightCycler 480
and Brilliant SYBR Green III Mastermix (Agilent) according to the manufacturer’s instruc-
tions. Primer sequences are included in S4 Table. Relative changes in expression levels (n-fold)
were calculated according to the 2-ΔΔCT method [72].
Northern blot analysis
Total RNA (10 μg) was separated on 8% (w/v) polyacrylamide [29:1 acrylamide/bisacrylamide],
7 M urea gels and electro-transferred onto positively charged nylon membranes (Roche). Hybrid-
ization probes (50 pmol; PB2Δ vRNA: 5’-TGAAAGGAATAGGAATGAGAAT-3’; PB2Δ c/
mRNA: 5’-ATTCTCATTCCTATTCCTTTCA-3’) were radioactively labeled using [γ-32P]-ATP
(PerkinElmer) and T4 Polynucleotide Kinase (Fermentas) according to the manufacturer’s in-
structions. Northern blot analysis was performed as described previously [73].
Mouse experiments
All animal experiments were performed in the BSL-3 animal facility of the Heinrich-Pette-In-
stitute, Leibniz Institute in Hamburg. BALB/c mice were obtained from the Harlan-Winkel-
mann animal breeding facilities. Eight-week-old mice were anaesthetized by intraperitoneal
injection of 100 mg/kg Ketavet and 10 mg/kg Xylazin. Mice were infected by the intranasal
route in a 50 μL volume as indicated. Health status of the animals was monitored daily accord-
ing to the animal protocols approved by the Hamburg authorities.
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of three independent experiments normalized to the respective RNA expression 2 h p.i..
(PDF)
S2 Fig. MS/MS spectrum of the tryptic C-terminal unique peptide KGQFPCVQL of the
H5N1 KAN-1 virus protein PB2Δ. 100 μg of protein mixtures from KAN-1-infected A549
cells were separated on a one-dimensional gel followed by in-gel digest by trypsin. LC-MS/MS
GenBank AAV35117 : polymerase basic protein 2 (PB2)
: (A/Thailand/1 (KAN-1)/2004
AAV35116 : polymerase basic protein 1 (PB1)
: (A/Thailand/1 (KAN-1)/2004)
AAV35113 : nonstructural protein 1 (NS1) (A/Thailand/1 (KAN-1)/2004)
AAV35112 : nucleoprotein (NP) (A/Thailand/1 (KAN-1)/2004)
AAV35110 : matrixprotein 1 (M1) (A/Thailand/1 (KAN-1)/2004)
ABO21695 : polymerase basic protein 2 (PB2) (A/Vietnam/1203/2004)
Q7Z434.2 : mitochondrial antiviral-signaling protein (MAVS)
AAA58459.1 : extracellular signal-regulated kinase 2 (ERK2)
CAG46616.1 : interferon alpha/beta receptor 2 (IFNAR2)
ADA59516.1 : signal transducer and activator of transcription 1 (STAT1)
AAM97604.1 : 2’-5’-oligoadenylate synthetase 1 (OAS-1) (mus musculus)
CAJ18612.1 : Myxovirus resistance protein 1 (Mx1) (mus musculus)
AAI38800.1 : interferon regulatory factor 7 (IRF7) (mus musculus)
Swiss-Prot O95786.2 : retinoic acid-inducible gene I (RIG-I)
P01574.1 : interferon beta
PRF 225751 : gamma interferon inducible gene IP10
doi:10.1371/journal.ppat.1004924.t001
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analyses were performed on an EasyLC nano-HPLC (Proxeon Biosystems) coupled to an LTQ
Orbitrap Elite mass spectrometer (Thermo Scientific). The MS data were processed using de-
fault parameters of the MaxQuant software (v1.2.2.9).
(PDF)
S3 Fig. Expressional changes of viral proteins in presence of PB2Δ protein. A549 cells were
infected with 5 MOI of rKAN-1 WT or PB2Δ for 2, 4, 6 or 8 h. Expression of viral proteins PB1,
PB2, NP, M1 and NS1 was analyzed by Western blot. Presence of PB2Δ was verified by using
PB2-specific antibodies. ERK2 expression served as loading control. Blots are representative of
three independent experiments.
(PDF)
S4 Fig. Effects of PB2Δ protein in vivo. BALB/c mice were infected with 50 pfu rKAN-1 wild
type or PB2Δ-expressing virus. A) Expression changes of IFNβmRNA in lungs were analyzed
two days p.i. by qRT-PCR. N-fold expression in individual animals normalized to uninfected
PBS control mice is depicted. B) Viral lung titers 2 days p.i. of individual animals are depicted.
A, B) Statistical significance was analyzed by Mann-Whitney test.
(PDF)
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